Prelude Therapeutics
PRLD
#9034
Rank
C$96.75 M
Marketcap
$1.76
Share price
5.83%
Change (1 day)
-56.40%
Change (1 year)

Earnings for Prelude Therapeutics (PRLD)

Earnings in 2024 (TTM): -C$0.2 Billion

According to Prelude Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$0.19 Billion a decrease over its 2022 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prelude Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.2 Billion5.02%
2023 -C$0.19 Billion7.07%
2022 -C$0.18 Billion8.62%
2021 -C$0.16 Billion93.55%
2020 -C$81.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion-12.06%๐Ÿ‡บ๐Ÿ‡ธ USA